Geode Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
Other funds holding FENC
ACM
AIC
PCA
Geode Capital Management's FENC Position: Q3 2026 in Review
Geode Capital Management increased its Fennec Pharmaceuticals (FENC) stake by 1.6% in Q3 2026, buying an estimated $71.4K and bringing the position to 409,061 shares worth $4.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2924.
Geode Capital Management first reported a position in FENC in Q2 2018 and has held it in 30 quarters since. 119 funds tracked by Wall St. Rank hold FENC as of Q3 2026.
- Geode Capital Management held 409,061 shares of Fennec Pharmaceuticals worth $4.36M as of Q3 2026.
- Geode Capital Management bought 6,495 Fennec Pharmaceuticals shares in Q3 2026, an estimated $71.4K.
- Fennec Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2924 holding.
- Geode Capital Management first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 30 quarters since.
- 119 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.